The official blog of the Lung Institute.
Company Looks to Help Patients with New Facility
Exciting news from the Lung Institute today! The company has opened its doors to a new clinic in Nashville, Tennessee! Patients will now be able to choose from two locations to help treat their pulmonary conditions.
The opening was marked by an official ribbon cutting ceremony from the medical staff, RMS corporate team, and members of the Nashville Chamber of Commerce. With Nashville being a hub for medical technology, this was a prime location to expand the Lung Institute brand. After the current success of treating 400 patients at the clinic in Tampa, FL., the new expansion will bring cellular therapys and innovative medicine to the Nashville area.
Jack Coleman, Jr, MD, is the medical director for the Lung Institute in Nashville. He earned his medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. Dr. Coleman is Board Certified in Otolaryngology and ensures that all treatments and staff will follow strict standards with the highest excellence in personalized patient care.
“I am very excited about these new facilities opening,” says Dr. Coleman. “The Lung Institute is providing innovative procedures for patients with debilitating conditions and will be a prime location for patients in Nashville.”
About the Lung Institute
Changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine, the Lung Institute has always committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive cellular therapies. These doctors have established a patient treatment plan with the highest concern for patient safety and quality of care.
Cellular Therapy for Lung Disease
The Lung Institute utilizes autologous cells, derived from the patient’s own body for both the venous (blood-derived) stem cell procedures. During these procedures, cells are extracted, isolated and then immediately introduced back into the body where they then divide and replicate into healthy cells specialized to the damaged tissue. Since the treatment uses the body’s own cells, there is a less chance for rejection. Both bone marrow and venous cells have shown anti-inflammatory properties beneficial to patients with lung disease.
If you suffer from a lung disease or know a loved one that disease, then cellular therapy is a viable option. If you have any questions, talk to one of our patient care coordinators today, contact us or call us at (800) 729-3065 to schedule a free consultation.